-
IDWeek 2024 Highlights: Advancements in RSV Prevention for Children with Vaccines and Monoclonal Antibodies
1. Clesrovimab for RSV Prevention in High-Risk Infants and Children RSV infects approximately 12.9 million infants globally each year, causing significant respiratory infections and hospitalizations, particularly in high-risk groups like…
-
2024 CACA Integrated Lung Cancer Conference | Prof. Li Zhang: Striving for Breakthroughs – The Advantages and Challenges of ADC Therapy for NSCLC
The 2024 CACA Integrated Lung Cancer Conference, organized by the Chinese Anti-Cancer Association and the CACA Lung Cancer Integration Committee, was held in Zhuhai from October 25 to 26. Under the theme “Gathering Strength and Leading the Future,” the conference brought together top experts in lung cancer to discuss key challenges and advancements. Oncology Frontier…
-
SIBCS 2024 | Hot Topics: China’s Breast Cancer Clinical Practice Controversy & Consensus Voting and a Preview of the 2025 CBCS Guidelines Update
From October 17 to 19, 2024, the 18th National Breast Cancer Conference and the 19th Shanghai International Breast Cancer Symposium (SIBCS 2024) took place in Shanghai. During this period, the fourth Controversy & Consensus Consortium (3C) Summit, focusing on clinical practice in Chinese breast cancer, was successfully held. Leading breast cancer experts and patient representatives…
-
The 9th Congress of the CCIHPBA l Dr.Tiangiang Song: Advancements Perioperative Treatments for Liver Cancer and the Tianiin Experience
The 9th Congress of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (CCIHPBA) and The Seminar on the Academic Thoughts of Prof. Oiu Fazu and his 110 Birth Anniversary and Sino -Geman Medical Educaton Fomum, along with A Commemorative Ceremony in honor of the late Prof. Wan Yee Joseph LAU, were held in Wuhan from…
-
A Review of the 2024 CCHIO/AOS International Forum I!
Adhering to the core concept of “Integrated Cancer Prevention and Treatment, Winning through Integration,” on November 14, 2024, a feast of knowledge on cancer prevention and treatment that brought together domestic and international medical elites, patient representatives, and leaders from all walks of life—The 2024 Chinese Congress on Holistic Integrative Oncology and The 40th Anniversary…
-
Dr. Jie’er Ying: Exploring New Pathways for Integrative Rehabilitation in Gastric Cancer to Improve Patient Outcomes
The 2024 CACA Integrative Gastric Cancer Conference took place in Wuhan from October 18-19, 2024. Oncology Frontier invited Dr. Jie’er Ying, Chairman of the Chinese Anti-Cancer Association’s Gastric Cancer Integrative Rehabilitation Committee and Head of the Hepatobiliary and Gastric Oncology Department at Zhejiang Cancer Hospital, to discuss the current state and development of integrative rehabilitation…
-
ESMO 2024丨Dr. Dingwei Ye: Exciting Advances with EGFR/HER3 Dual-Antibody ADC, New Successes in Urologic Oncology
The 2024 European Society for Medical Oncology (ESMO) Congress was held from September 13 to 17 in Barcelona, Spain. During the event, multiple key studies in urologic oncology were highlighted. Dr. Dingwei Ye from Fudan University Shanghai Cancer Center presented preliminary findings on the safety, tolerability, and efficacy of BL-B01D1, a novel EGFR/HER3 dual-targeting antibody-drug…
-
ILCA 2024丨Dr. Yunfei Yuan: REFINE Study Reports Subgroup Data for Interventional Therapy
The 18th International Liver Cancer Association (ILCA) Annual Conference took place in Toronto, Canada, from October 17-19, 2024. During the conference, Prof. Richard S. Finn of the David Geffen School of Medicine at UCLA presented subgroup data from the real-world REFINE study, highlighting that patients with unresectable hepatocellular carcinoma (uHCC) who received transarterial chemoembolization (TACE)…
Connecting Medical Expertise through Media